From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments

Wait 5 sec.

Singapore startups are tapping China’s vast patient pool, hospital networks and manufacturing capabilities, but they must also navigate its evolving regulatory landscape.